Uncategorized

Anxiety and outcome in bipolar disorder.

Anxiety and outcome in bipolar disorder. Related Articles Anxiety and outcome in bipolar disorder. Am J Psychiatry. 2009 Nov;166(11):1238-43 Authors: Coryell W, Solomon DA, Fiedorowicz JG, Endicott J, Schettler PJ, Judd LL OBJECTIVE: Important differences exist between bipolar disorder with and without comorbid anxiety, but little is known about the long-term prognostic significance of coexisting …

Anxiety and outcome in bipolar disorder. Read More »

Effect of acute antidepressant administration on negative affective bias in depressed patients.

Effect of acute antidepressant administration on negative affective bias in depressed patients. Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiatry. 2009 Oct;166(10):1178-84 Authors: Harmer CJ, O’Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, Goodwin GM, Cowen PJ OBJECTIVE: Acute administration of an antidepressant increases positive affective …

Effect of acute antidepressant administration on negative affective bias in depressed patients. Read More »

To Sleep, Perchance to Reset Your Body Clock

To Sleep, Perchance to Reset Your Body Clock January 9, 2010 Psychiatric Times. Vol. 27 No. 2 Alfred J. Lewy, MD, PhD Dr Lewy is professor of psychiatry, ophthalmology, and physiology/pharmacology, senior vice chairman of the department of psychiatry, and director of the sleep and mood disorders laboratory at the Oregon Health & Science University, …

To Sleep, Perchance to Reset Your Body Clock Read More »

Testosterone Augmentation Therapy Reduces Major Depressive Disorder Severity

Low-dose Transdermal Testosterone Augmentation Therapy Improves Depression Severity in Women Karen K. Miller, MD, Roy H. Perlis, MD, MSc, George I. Papakostas, MD, David Mischoulon, MD, PhD, Dan V. Iosifescu, MD, MSc, Danielle J. Brick, BA, and Maurizio Fava, MD CNS Spectr. 2009;14(12):688-694 [download PDF] Background: Inadequate response to antidepressant monotherapy in women with major …

Testosterone Augmentation Therapy Reduces Major Depressive Disorder Severity Read More »

Urate as a predictor of the rate of clinical decline in Parkinson disease.

Urate as a predictor of the rate of clinical decline in Parkinson disease. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol. 2009 Dec;66(12):1460-8 Authors: Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, …

Urate as a predictor of the rate of clinical decline in Parkinson disease. Read More »

Reduced function of the serotonin transporter is associated with decreased expression of BDNF

Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. Related Articles Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. Neurobiol Dis. 2009 Dec 23; Molteni R, Cattaneo A, Calabrese F, Macchi F, …

Reduced function of the serotonin transporter is associated with decreased expression of BDNF Read More »

Chronic psychosocial stress triggers cognitive impairment in Alzheimer’s disease

Chronic psychosocial stress triggers cognitive impairment in a novel at-risk model of Alzheimer’s disease Neurobiology of Disease, In Press, Accepted Manuscript, Available online 4 January 2010Trinh T., Tran , Marisa, Srivareerat , Karim A., Alkadhi Abstract Although it is generally accepted that Aβ contributes to the pathogenesis of Alzheimer’s disease (AD), other factors that impact …

Chronic psychosocial stress triggers cognitive impairment in Alzheimer’s disease Read More »

Interleukin-1beta impairs memory by reducing acetylcholine release and nerve growth factor expression, reversed by Omega-3 Fatty Acid EPA treatment

Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment. Related Articles Reductions of acetylcholine release and nerve growth factor expression are correlated with memory impairment induced by interleukin-1beta administrations: effects of omega-3 fatty acid EPA treatment. J Neurochem. 2009 …

Interleukin-1beta impairs memory by reducing acetylcholine release and nerve growth factor expression, reversed by Omega-3 Fatty Acid EPA treatment Read More »

Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides.

Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides.: “ Related Articles Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. J Neurochem. 2009 Nov 6; Authors: Davenport CM, Sevastou IG, Hooper C, Pocock JM Microglial activation can lead to microglial apoptosis, which may serve to remove …

Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. Read More »

Is Heart Failure a Mental Illness? – MAO Inhibitors offers promise in treating heart failure

Is Heart Failure a mental illness? At the very least, it is a psychosomatic illness as this press release indicates. ———- Public release date: 6-Jan-2010 Contact: David March dmarch1@jhmi.edu 410-955-1534 Johns Hopkins Medical Institutions Old antidepressant offers promise in treating heart failure Monoamine oxidase-A inhibitor drug blocks buildup of toxic free radicals in animal hearts …

Is Heart Failure a Mental Illness? – MAO Inhibitors offers promise in treating heart failure Read More »

Scroll to Top